Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase III comparative study of vinorelbine (VNB) combined with doxorubicin (DOX) vs. doxorubicin alone in metastatic/recurrent breast cancer (MBC): a National Cancer Institute of Canada (NCIC-CTG) study

A phase III comparative study of vinorelbine (VNB) combined with doxorubicin (DOX) vs. doxorubicin alone in metastatic/recurrent breast cancer (MBC): a National Cancer Institute of Canada (NCIC-CTG) study. Proc Annu Meet Am Soc Clin Oncol. 1996; 15:A59.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.